Hyperfibrinogenemia increases the risk of cardiac events after coronary artery stenting

Heart and Vessels

Volumn 15, Issue 6, 2000, Pages 263-267

  Germing, A ^a   Von Dryander, S ^a   Machraoui, A ^a   Bojara, W ^a   Lawo, T ^a   Grewe, P ^a   Barmeyer, J ^a   Lemke, B ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Adverse cardiac events; Coronary artery stenting; Fibrinogen

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TICLOPIDINE; TRIACYLGLYCEROL; WARFARIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CLINICAL LABORATORY; CLINICAL PRACTICE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DEATH; DISEASE ASSOCIATION; EXERCISE; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN DEFECT; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PRIORITY JOURNAL; THROMBOSIS; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHOLESTEROL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; RECURRENCE; RISK FACTORS; STENTS; THROMBOSIS;

EID: 0034547947     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003800070003     Document Type: Article

References (29)

1. Predictors of restenosis after coronary stent implantation
2. Pathophysiology and therapeutic concepts in coronary restenosis
3. The stent decade: 1987 to 1997
4. Fibrinogen and risk of cardiovascular disease: The Framingham Study
5. Hemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
6. Fibrinogen as a risk factor for stroke and myocardial infarction
7. Fibrinogen, viscosity and white blood cell count are major risk factors for ischemic heart disease: The Caerphilly and Speedwell collaborative heart disease studies
8. Fibrinogen, factor VII clotting activity and coronary artery disease severity
9. Baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography
10. Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis
11. Haemostatic and rheological factors as predictors of restenosis following percutaneous transluminal angioplasty
12. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty
13. Hyperfibrinogenämie bei Rezidivstenose nach High-Pressure-Koronarstenting
14. Der akute Koronargefäßverschluß nach PTCA - Möglichkeit der Risikostratifizierung mittels quantitativer Koronarangiographie, klinischer Determinanten und laborchemischer Daten
15. Fibrinogen after coronary angioplasty as a risk factor for restenosis
16. Quantitative coronary angiography in clinical practice
17. Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting
18. Atherogenesis and plasma constituents
19. Fibrin and atherogenesis - A hypothesis
20. Early changes in aortic intima
21. The acute phase reaction and haematological stress syndrome in vascular disease
22. Role of endothelium in sequestration of lipoprotein and fibrinogen in aortic lesions thrombi and graft pseudointimas
23. Haemostatic factors in human aortic intima
24. Fibrinogen/fibrin in atherogenesis
25. Fibrinogen plasma levels as a marker of thrombin activation: New insights on the role of fibrinogen as a cardiovascular risk factor
26. Monocyte adherence to endothelial cells in patients with atherosclerosis: Relationships with risk factors
27. Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: The remodeling paradox
28. Pre-existing arterial remodeling is associated with in-hospital and late adverse cardiac events after coronary interventions in patients with stable angina pectoris
29. Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris